Why Pharma Must Transform Now? A strategic Imperative
EducationalTRANSFORMING MANUFACTURING PROCESSES FOR A LOW-IMPACT PHARMA INDUSTRY
2026-05-27 | 01:00 PM - 01:15 PM | TPSD Room
Abstract
Why Now?
Pharma faces growing cost volatility and tightening regulation that threaten margins and operational stability. Transformation is no longer optional, it is critical to managing risk and optimizing resources.
- Cost pressures & regulatory complexity
- Where the footprint sits
- How to transform?
- Call to Action: Unlocking ROI from decarbonanization
Transformation is urgent, actionable, and financially justified.
